← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Speragen, Inc.
Austin, TX
$671,069
Total funding
3
Grants
Funding over time
peak $446.1K · FY2016–18$500K$375K$250K$125K$0
'16
'17
'18
Funding mix
By agency
NIH$671,069 · 3
By mechanism
R41$671,069 · 3
Investigators at Speragen, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Preclinical Evaluation of NCS-382 in Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD)$224,936
R41 · FY2016 · NS
Farnesol as Novel Treatment in Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD)$223,095
R41 · FY2018 · NS
In Silico Identification of Novel GHB Receptor Ligands for SSADH Deficiency, a Disorder of GABA Metabolism$223,038
R41 · FY2018 · NS